955 related articles for article (PubMed ID: 19640573)
21. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
Heibl C; Trommet V; Burgstaller S; Mayrbaeurl B; Baldinger C; Koplmüller R; Kühr T; Wimmer L; Thaler J
Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
[TBL] [Abstract][Full Text] [Related]
22. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
23. Changing concepts in long-term central venous access: catheter selection and cost savings.
Horattas MC; Trupiano J; Hopkins S; Pasini D; Martino C; Murty A
Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for catheter-related thrombosis in cancer patients.
Tesselaar ME; Ouwerkerk J; Nooy MA; Rosendaal FR; Osanto S
Eur J Cancer; 2004 Oct; 40(15):2253-9. PubMed ID: 15454250
[TBL] [Abstract][Full Text] [Related]
25. Totally implantable central venous access ports. Analysis of 700 cases.
Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
[TBL] [Abstract][Full Text] [Related]
26. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
27. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
[TBL] [Abstract][Full Text] [Related]
28. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic complications of central venous catheters in cancer patients.
Bona RD
Semin Thromb Hemost; 1999; 25(2):147-55. PubMed ID: 10357082
[TBL] [Abstract][Full Text] [Related]
30. Complication rates and outcomes of 536 implanted subcutaneous chest ports: do rates differ based on the primary operator's level of training?
Silas AM; Perrich KD; Hoffer EK; McNulty NJ
Acad Radiol; 2010 Apr; 17(4):464-7. PubMed ID: 20060749
[TBL] [Abstract][Full Text] [Related]
31. Management of totally implantable vascular access devices in patients with cystic fibrosis.
Dal Molin A; Gatta C; Festini F
Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
Schwarz RE; Groeger JS; Coit DG
Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
[TBL] [Abstract][Full Text] [Related]
33. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
[TBL] [Abstract][Full Text] [Related]
34. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
35. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
[TBL] [Abstract][Full Text] [Related]
36. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.
Lee AY; Levine MN; Butler G; Webb C; Costantini L; Gu C; Julian JA
J Clin Oncol; 2006 Mar; 24(9):1404-8. PubMed ID: 16549834
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
Revel-Vilk S; Yacobovich J; Tamary H; Goldstein G; Nemet S; Weintraub M; Paltiel O; Kenet G
Cancer; 2010 Sep; 116(17):4197-205. PubMed ID: 20533566
[TBL] [Abstract][Full Text] [Related]
38. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
40. [Long-term outcomes and complications of upper arm central venous access ports].
Ide Y; Mikami K; Murata K
Gan To Kagaku Ryoho; 2013 Mar; 40(3):331-5. PubMed ID: 23507594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
